These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 11798142)

  • 21. Cytokine responses to physical activity, with particular reference to IL-6: sources, actions, and clinical implications.
    Shephard RJ
    Crit Rev Immunol; 2002; 22(3):165-82. PubMed ID: 12498381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relevance of some growth factors to cardiovascular disease in maintenance hemodialysis patients].
    Borawski J; Myśliwiec M
    Pol Merkur Lekarski; 2006 Aug; 21(122):117-8; discussion 119. PubMed ID: 17144092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dyslipidemia, inflammation and dialysis outcomes: what we know now.
    Krane V; Drechsler C; Wanner C
    Curr Opin Nephrol Hypertens; 2006 Nov; 15(6):566-70. PubMed ID: 17053468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malnutrition in hemodialysis patients: what therapy?
    Bossola M; Muscaritoli M; Tazza L; Giungi S; Tortorelli A; Rossi Fanelli F; Luciani G
    Am J Kidney Dis; 2005 Sep; 46(3):371-86. PubMed ID: 16129199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodialysis, inflammation and malnutrition.
    Cano N
    Nefrologia; 2001; 21(5):437-42. PubMed ID: 11795011
    [No Abstract]   [Full Text] [Related]  

  • 26. Quotidian hemodialysis and inflammation associated with chronic kidney disease.
    Hamlett L; Haragsim L
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):e35-42. PubMed ID: 17603973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microinflammation is involved in the dysfunction of arteriovenous fistula in patients with maintenance hemodialysis.
    Liu BC; Li L; Gao M; Wang YL; Yu JR
    Chin Med J (Engl); 2008 Nov; 121(21):2157-61. PubMed ID: 19080177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytokines, metalloproteinases, neopterin and cardiovascular mortality among patients with chronic renal failure].
    Kościów K; Małecki R; Adamiec R
    Pol Merkur Lekarski; 2007 Jan; 22(127):54-7. PubMed ID: 17477092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic obstructive pulmonary disease: effects beyond the lungs.
    Balasubramanian VP; Varkey B
    Curr Opin Pulm Med; 2006 Mar; 12(2):106-12. PubMed ID: 16456379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mediators of amyloidogenesis and cytokines in dialysis-related amyloidosis].
    Rysavá R; Merta M; Tesar V; Lachmanová J; Sulková S; Bláha J
    Cas Lek Cesk; 2002 Apr; 141(8):244-7. PubMed ID: 12038073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammation and malnutrition as predictors of mortality in patients on hemodialysis.
    Fernández-Reyes MJ; Alvarez-Ude F; Sánchez R; Mon C; Iglesias P; Díez JJ; Vázquez A
    J Nephrol; 2002; 15(2):136-43. PubMed ID: 12018629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic inflammation increases risk in hemodialysis patients.
    Razeghi E; Omati H; Maziar S; Khashayar P; Mahdavi-Mazdeh M
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):785-9. PubMed ID: 18711296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrapure dialysate: facts and myths.
    Bommer J; Jaber BL
    Semin Dial; 2006; 19(2):115-9. PubMed ID: 16551288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokine production in haemodialysis.
    Memoli B
    Blood Purif; 1999; 17(2-3):149-58. PubMed ID: 10449873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does periodontitis reflect inflammation and malnutrition status in hemodialysis patients?
    Chen LP; Chiang CK; Chan CP; Hung KY; Huang CS
    Am J Kidney Dis; 2006 May; 47(5):815-22. PubMed ID: 16632020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Could anti-inflammatory cytokine therapy improve poor treatment outcomes in dialysis patients?
    Macdougall IC
    Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V73-78. PubMed ID: 15284364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vascular access, an underestimated source of inflammation in dialysis patients].
    Canaud B; Sénécal L; Leray-Moragués H; Picard-Gontiers A; Terrier N; Morena M; Cristol JP
    Nephrologie; 2003; 24(7):353-8. PubMed ID: 14650746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roquinimex-mediated protection effect on the development of chronic graft-versus-host disease in mice is associated with induction of Th1 cytokine production and inhibition of proinflammatory cytokine production.
    Xiao ZY; Zhou WX; Zhang YX; Cheng JP; He JF; Yang RF; Yun LH
    Life Sci; 2007 Oct; 81(19-20):1403-10. PubMed ID: 17950363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malnutrition-inflammation complex syndrome and hepatitis C in maintenance hemodialysis patients.
    Vlatkovic V; Trbojevic-Stankovic J; Stojimirovic B
    Ther Apher Dial; 2009 Apr; 13(2):113-20. PubMed ID: 19379150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inflammatory status in patients with end-stage renal disease: role of monocyte activation].
    Liang M; Wang L; Hou FF; Liu J; Liu ZQ; Tian JW
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):781-4. PubMed ID: 12919896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.